These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 29459693

  • 1. Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance.
    Manzoor S, Bilal A, Khan S, Ullah R, Iftikhar S, Emwas AH, Alazmi M, Gao X, Jawaid A, Saleem RSZ, Faisal A.
    Sci Rep; 2018 Feb 19; 8(1):3305. PubMed ID: 29459693
    [Abstract] [Full Text] [Related]

  • 2. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM.
    Invest New Drugs; 2020 Jun 19; 38(3):584-598. PubMed ID: 31177401
    [Abstract] [Full Text] [Related]

  • 3. Structural insight into SSE15206 in complex with tubulin provides a rational design for pyrazolinethioamides as tubulin polymerization inhibitors.
    Ma L, Lei J, Chen H, Huang R, Su T, Feng J, Sun Q.
    Future Med Chem; 2022 Jun 19; 14(11):785-794. PubMed ID: 35506429
    [Abstract] [Full Text] [Related]

  • 4. 2-APCAs, the Novel Microtubule Targeting Agents Active Against Distinct Cancer Cell Lines.
    Boichuk S, Galembikova A, Bikinieva F, Dunaev P, Aukhadieva A, Syuzov K, Zykova S, Igidov N, Ksenofontov A, Bocharov P.
    Molecules; 2021 Jan 25; 26(3):. PubMed ID: 33503939
    [Abstract] [Full Text] [Related]

  • 5. CPPF, A Novel Microtubule Targeting Anticancer Agent, Inhibits the Growth of a Wide Variety of Cancers.
    Han HJ, Park C, Hwang J, N R T, Kim SO, Han J, Woo M, B S, Ryoo IJ, Lee KH, Cha-Molstad H, Kwon YT, Kim BY, Soung NK.
    Int J Mol Sci; 2020 Jul 07; 21(13):. PubMed ID: 32645923
    [Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH, Jiang JD, Holland JF, Perez-Soler R.
    Mol Pharmacol; 2002 Sep 07; 62(3):529-38. PubMed ID: 12181429
    [Abstract] [Full Text] [Related]

  • 7. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
    Gupta AK, Tulsyan S, Bharadwaj M, Mehrotra R.
    Top Curr Chem (Cham); 2019 May 09; 377(3):15. PubMed ID: 31073777
    [Abstract] [Full Text] [Related]

  • 8. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY.
    J Pharmacol Exp Ther; 2007 Oct 09; 323(1):398-405. PubMed ID: 17660383
    [Abstract] [Full Text] [Related]

  • 9. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK, Han EK, Credo B, Jae HS, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng SC.
    Cancer Res; 2001 Jul 15; 61(14):5480-5. PubMed ID: 11454695
    [Abstract] [Full Text] [Related]

  • 12. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
    Leoni LM, Hamel E, Genini D, Shih H, Carrera CJ, Cottam HB, Carson DA.
    J Natl Cancer Inst; 2000 Feb 02; 92(3):217-24. PubMed ID: 10655438
    [Abstract] [Full Text] [Related]

  • 13. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC.
    Clin Cancer Res; 2005 Aug 15; 11(16):6002-11. PubMed ID: 16115945
    [Abstract] [Full Text] [Related]

  • 14. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
    Zang X, Wang G, Cai Q, Zheng X, Zhang J, Chen Q, Wu B, Zhu X, Hao H, Zhou F.
    Drug Metab Dispos; 2018 May 15; 46(5):542-551. PubMed ID: 29523600
    [Abstract] [Full Text] [Related]

  • 15. Design, Synthesis, and Biological Evaluation of SSE1806, a Microtubule Destabilizer That Overcomes Multidrug Resistance.
    Firdous F, Riaz S, Furqan M, Fozail S, Fatima K, Pohl SÖ, Doleschall NJ, Myant KB, Kahfi J, Emwas AH, Jaremko M, Chotana GA, Saleem RSZ, Faisal A.
    ACS Med Chem Lett; 2023 Oct 12; 14(10):1369-1377. PubMed ID: 37849542
    [Abstract] [Full Text] [Related]

  • 16. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.
    Nakagawa-Goto K, Oda A, Hamel E, Ohkoshi E, Lee KH, Goto M.
    J Med Chem; 2015 Mar 12; 58(5):2378-89. PubMed ID: 25695315
    [Abstract] [Full Text] [Related]

  • 17. A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.
    Ahmed AA, Goldsmith J, Fokt I, Le XF, Krzysko KA, Lesyng B, Bast RC, Priebe W.
    Cancer Chemother Pharmacol; 2011 Oct 12; 68(4):1033-44. PubMed ID: 21340606
    [Abstract] [Full Text] [Related]

  • 18. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH.
    Mol Pharmacol; 2004 Jan 12; 65(1):77-84. PubMed ID: 14722239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
    Hasanpourghadi M, Karthikeyan C, Pandurangan AK, Looi CY, Trivedi P, Kobayashi K, Tanaka K, Wong WF, Mustafa MR.
    J Exp Clin Cancer Res; 2016 Mar 31; 35():58. PubMed ID: 27030360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.